Hyphens Pharma International Limited is a leading pharmaceutical company in Southeast Asia, primarily involved in the development, marketing, and distribution of a wide array of healthcare products. The company focuses on a diversified portfolio that includes specialty pharmaceuticals, proprietary health supplements, and medical devices. Its operations are segmented into three main business units: Specialty Pharma Principals, Proprietary Brands, and Medical Hypermart and Digital. Hyphens Pharma has been instrumental in introducing proprietary health supplements like Ceradan in the dermatological space and Ocean Health in the nutraceutical segment. The company serves hospitals, clinics, and pharmacies, providing essential healthcare products across Singapore, Vietnam, Malaysia, and other regional markets. Headquartered in Singapore, Hyphens Pharma's role in the market is critical as it bridges the gap between cutting-edge healthcare innovations and consumers in fast-growing Asian markets, supporting health and wellness advancements through strategic partnerships and a comprehensive distribution network.
Markedsdata leveret af TwelveData og Morningstar
Baseret på 2 analytikere